GBIO — Generation Bio Co Income Statement
0.000.00%
Last trade - 00:00- $41.63m
- -$99.74m
- $19.89m
- 36
- 51
- 25
- 29
Annual income statement for Generation Bio Co, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0 | 0 | 5.9 | 19.9 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 81.1 | 119 | 141 | 144 | 162 |
| Operating Profit | -81.1 | -119 | -141 | -139 | -142 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -80.5 | -119 | -137 | -127 | -132 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -80.5 | -119 | -137 | -127 | -132 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -80.5 | -119 | -137 | -127 | -132 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -80.5 | -119 | -137 | -127 | -132 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -17.4 | -21.2 | -22.5 | -19.6 | -10.2 |